GGrantIndex
Sort

39,280 grants matching leukemia

Calreticulin-mediated protein folding in health and disease

$458,052
Malini Raghavan · University Of Michigan At Ann Arbor · R01 · FY2022 · AI

Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer

$458,029
Alice Berger · Fred Hutchinson Cancer Center · R37 · FY2023 · CA

Immunotherapy of low grade lymphoid malignancies

$457,995
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL

O-Glycosylation of Epidermal Growth Factor-like Modules

$457,994
Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2009 · GM

01 - Cancer Biology & Immunology

$457,961
Robert S Welner · University Of Alabama At Birmingham · P30 · FY2025 · CA

Targeted therapy for t(8;21)+ AML

$457,843
Stephen David Nimer · University Of Miami School Of Medicine · R01 · FY2024 · CA

MOLECULAR STUDIES OF DRUG RESISTANCE IN CHRONIC LYMPHOCY

$457,778
Ohio State University · R01 · FY2001 · CA

NCTN Deep South Research Consortium

$457,700
Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2024 · CA

REGULATION OF GENE EXPRESSION BY DNA BINDING LIGANDS

$457,664
California Institute Of Technology · R01 · FY2002 · GM

Targeting PML for Leukemia Therapy

$457,619
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA

Role of TIF1y in Erythropoiesis

$457,596
Leonard I Zon · Boston Children'S Hospital · P01 · FY2007 · HL

Genetic Approaches to Hemoglobin Switching

$457,592
Stuart H Orkin · Boston Children'S Hospital · P01 · FY2007 · HL

Regulation of EBV Latency by Purine Metabolism and Signaling

$457,575
Italo Tempera · Wistar Institute · R01 · FY2025 · AI

Long non-coding RNAs in hematopoiesis and blood malignancy

$457,533
Iannis Aifantis · New York University School Of Medicine · R01 · FY2016 · CA

Long non-coding RNAs in hematopoiesis and blood malignancy

$457,533
Iannis Aifantis · New York University School Of Medicine · R01 · FY2015 · CA

Long non-coding RNAs in hematopoiesis and blood malignancy

$457,533
Iannis Aifantis · New York University School Of Medicine · R01 · FY2018 · CA

Long non-coding RNAs in hematopoiesis and blood malignancy

$457,533
Iannis Aifantis · New York University School Of Medicine · R01 · FY2017 · CA

Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy

$457,521
Navin Varadarajan · University Of Houston · R01 · FY2014 · CA

Mechanisms regulating the B lymphopoiesis fetal/adult switch

$457,500
Kyoko Hayakawa · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · AI

Mechanisms regulating the B lymphopoiesis fetal/adult switch

$457,500
Kyoko Hayakawa · Research Inst Of Fox Chase Can Ctr · R01 · FY2017 · AI

Dissecting the mechanisms through which Wnt5 signaling influences hematopoiesis

$457,500
Juliet Girard · University Of Massachusetts Boston · R15 · FY2025 · HL

Targeting PML for leukemia therapy.

$457,498
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA

Mechanisms/Transformation by TAL1/SCL in Thymic Neoplasm

$457,441
A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2006 · CA

Genetic analysis of mouse chromosome 11

$457,430
Monica Jean Justice · Baylor College Of Medicine · R01 · FY2007 · CA

4'-Substituted nucleoside analogs as anticancer drugs

$457,367
John A Secrist · Southern Research Institute · R01 · FY2008 · CA